TABLE 1.

Primary and secondary arrhythmias due to chemotherapy-related cardiotoxicity.

Classification of CDIA	Classification of chemotherapeutic agents	Cardiotoxicity endpoint	References
Primary	Anthracyclines	QTc interval prolongation	Buza et al. (2017)
	Thalidomide	——	Rajkumar et al. (2003)
	Alectinib, Ceritinib, Crizotinib, Ibrutinib, Ponatinib	QTc interval prolongation	Buza et al. (2017)
	Cisplatin	QTc interval prolongation	Thix et al. (2009)
Secondary	Anthracyclines	Cardiomyopathy	Buza et al. (2017)
	5-Fluorouracil	Myocardial ischemia	Khan, et al. (2012)
	bortezomib, carfilzomib	Heart failure	Buza et al. (2017)
	Dasatinib	Cardiomyopathy	Buza et al. (2017)
	sunitinib	Heart failure	Buza et al. (2017)
	Trastuzumab	Left ventricular systolic dysfunction	Piotrowski et al. (2012)
	Pembrolizumab, nivolumab	Myocarditis	Heinzerling et al. (2016), Behling et al. (2017)

——: Not mentioned.